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1. Introduction
The  cornea  is  composed  of  a  multilayered  epithelium,  Bowman's  membrane,  stroma,
Descemet's membrane, and endothelium. The corneal endothelium (CE) is a single layer
of hexagonal cells that separates the corneal stroma from the aqueous humor of the anterior
chamber.  Transparency  of  the  cornea  is  maintained  by  regulation  of  stromal  hydration
through the barrier and pump functions of the CE, and corneal transplantation has long
been used to treat corneal endothelial defects. In fact, more than half of the patients who
undergo  full-thickness  corneal  transplantation  have  impairment  of  visual  acuity  due  to
corneal  endothelial  problems alone and have a  normal  corneal  epithelium (Cosar  et  al.,
2002;  Mannis et  al.,  1981;  Rapuano et  al.,  1990).  Corneal transplantation requires a fresh
human cornea, but there is a worldwide shortage of donors (Barboza et al.,  2007; Cao et
al., 2006; Shimazaki et al., 2004; Tuppin et al., 2007).
Stem cells or progenitor cells are defined by a capacity for self-renewal and the ability to
generate different types of  cells  (multipotentiality)  that  are involved in the formation of
mature tissues. In contrast, precursor cells are unipotential cells with limited proliferative
capacity. Regenerative stem cells or precursors can be detected by the sphere-forming assay
in various adult  tissues,  including the central  nervous system (Nunes et  al.,  2003),  bone
marrow (Krause et al., 2001), skin (Kawase et al., 2004; Toma et al., 2001), retina (Coles et
al.,  2004),  corneal  epithelium (Mimura  et  al.,  2010a;  Yokoo  et  al.,  2008),  corneal  stroma
(Amano et al., 2006; Mimura, 2008a, 2008b; Uchida et al., 2005; Yamagami et al., 2007), and
corneal  endothelium  (Amano  et  al.,  2006;  Mimura,  2005a,  2005b,  2005c,  2007,  2010b;
Yamagami, 2006, 2007; Yokoo et al., 2005).
© 2013 Mimura et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Despite the successful isolation and characterization of stem cells from various tissues,
relatively few animal studies have been done to investigate the efficacy of stem cell transplan‐
tation. A three-dimensional carrier that maintains cell-to-cell interactions is indispensable for
tissue engineering using stem cells, but the resulting structural complexity does not allow us
to easily perform investigations of stem cell transplantation.
We have isolated precursors with the propensity to develop into corneal endothelial-like
cells from the CE of human donor corneas (Yokoo et al., 2005). We have also demonstrat‐
ed that cultured human corneal endothelial cells (HCECs) and rabbit CE-derived precur‐
sors are an effective cell source for treating corneal endothelial defects in a rabbit model
(Mimura 2005a, 2005b). Because the number of corneal endothelial cell  (CEC) precursors
that  can  be  isolated  from  a  native  cornea  is  insufficient  for  corneal  transplantation,
establishment of  a method for the mass production of precursor cells  is  required before
CEC transplantation can be employed clinically.
In this chapter, we introduce our recent work in the fields of regenerative medicine and tissue
engineering for the CE using bipotential precursor cells. We isolated precursors with the
propensity to develop into CECs from human CE, and we investigated the distribution and
proliferative capacity of precursor cells derived from the central and peripheral regions of the
cornea by the sphere-forming assay. We also tested the effect of injecting human corneal
endothelial spheres anterior chamber (instead of full-thickness corneal transplantation) in a
rabbit model of bullous keratopathy, a condition associated with corneal endothelial defects.
2. Origin and development of the Corneal Endothelium
Neural crest cells, from which the CE is derived (Bahn et al., 1984; Johnston et al., 1979), migrate
and differentiate in two waves during corneal development (Liu et al., 1998; Meier et al.,
1982). In the first wave, the corneal epithelium is formed by periocular mesenchymal cells of
neural crest origin and it synthesizes the primary stroma, after which neural crest cells migrate
to the margin of the optic cup and then migrate between the lens and corneal epithelium to
contribute to development of the CE and the trabecular meshwork. In the second wave, neural
crest cells invade the primary stroma and differentiate into corneal keratocytes.
3. Isolation of sphere colonies from human Corneal Endothelium
3.1. Primary sphere-forming assay
This study was conducted in accordance with the Declaration of Helsinki. Corneas were
obtained from the Central Florida Lions Eye Tissue Bank and the Rocky Mountain Lions’ Eye
Bank at 4 to 10 days after death. The age of the donors was 41 to 78 years. The CE and
Descemet’s membrane were peeled away in a sheet from the periphery to the center of the
inner surface of the cornea with fine forceps, as described previously (Sakai et al., 2002). To
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avoid the inclusion of posterior stromal tissue, we only used endothelium that was smoothly
peeled off together with Descemet’s membrane. The harvested CE was incubated at 37ºC for
3 hours in basal medium containing 0.02% collagenase (Sigma-Aldrich, St. Louis, MO). This
was followed by incubation in 0.2% ethylenediaminetetraacetic acid (EDTA) at 37ºC for 5
minutes, and then dissociation into single cells by trituration with a fire-polished Pasteur
pipette. The viability of the isolated CECs was >90%, as shown by trypan blue staining (Wako
Pure Chemical Industries, Osaka, Japan). After addition of a trypsin inhibitor (Invitrogen-
Gibco), the cells were resuspended in basal medium and the number of cells was counted
(Coulter counter; Beckman-Coulter, Hialeah, FL). Neither cytokeratin-3 nor cytokeratin-12
expression was detected, indicating that the cells thus obtained were all CECs without
contamination by other corneal cell types.
Half of the cells were labeled with a fluorescent cell tracker (CM-DiI; C-7000; Molecular Probes,
Eugene, OR), as described elsewhere (Mimura et al. 2004), to examine sphere formation by
reaggregation. DiI-labeled cells and unlabeled cells were mixed and seeded at a density of 1
cell/μL (250 cells/cm2), 10 cells/μL (2,500 cells/cm2), 30 cells/μL (7,500 cells/cm2), or 50 cells/μL
(12,500 cells/cm2) on 60-mm uncoated dishes containing 5 mL of medium for floating culture
(Reynolds & Weiss, 1992, 1996) (Fig. 1B). No spheres were generated in the cultures with only
1 viable cell/μL, but numerous spheres were formed at 30 and 50 cells/μL, with some arising
from reaggregation as indicated by DiI staining. Spheres were completely DiI-positive or DiI-
negative when culture was performed at 10 cells/μL (Fig. 1C), indicating that these spheres
were derived from proliferation and not from reaggregation of the dissociated cells.
Incubation was done in a humidified incubator under an atmosphere of 5% CO2, with 40
ng/mL basic fibroblast growth factor (bFGF) and 20 ng/mL epidermal growth factor (EGF)
being added to the medium every other day. To investigate whether the isolated cells were
contaminated with corneal epithelial cells, expression of epithelial markers such as keratins
K3 and K12 (Irvine et al., 1997; Moll et al., 1982) was assessed by the reverse transcription–
polymerase chain reaction (RT-PCR) before the start of culture. Then primary culture was
performed and the existence of fibroblast-like cells was investigated to assess contamination
by stromal cells. CECs were isolated without contamination by corneal epithelial cells, as
demonstrated by RT-PCR analysis of corneal epithelial markers (K3 and K12 genes), as well
as the characteristic hexagonal shape of the cells in primary culture (data not shown). Almost
complete disaggregation into single cells was achieved, since counting of single, double, and
triple cells showed that 99% of all cells were single (Fig. 1B).
After incubation for 5 days, small floating spheres formed. These spheres grew larger after 10
days, while the nonproliferating cells died and were eliminated (Fig. 1D). After 10 days, we
only counted cell clusters with a diameter of at least 50 μm, in order to distinguish growing
spheres from dying ones. To verify that the increase of colony size was actually due to cell
proliferation, we added the thymidine analogue BrdU to cultures at 24 hours before fixation.
Then the spheres were stained with an FITC-conjugated anti-BrdU antibody (1:100; Roche
Diagnostics, Basel, Switzerland) at room temperature (RT) for 60 minutes in the dark. We found
that BrdU labeled most of the cells in each sphere on day 10 (Fig. 1E), indicating that the spheres
contained proliferating cells. These results suggested that the sphere colonies arose from single
Corneal Endothelial Tissue Bioengineering Using Cultured Human Corneal Endothelial Precursor Cells
http://dx.doi.org/10.5772/55541
431
isolated HCECs and that the sphere-forming cells possess the capacity to proliferate. When
the number of spheres obtained was counted after 10 days of culture, we found that 257 ± 83
spheres (mean ± SD, n=8) were generated per dish (50,000 cells). In a typical case, 2.5 ± 104 cells
were isolated from a 10-mm piece of corneal tissue, generating approximately 130 spheres after
10 days. These spheres had a diameter of 88.3 ± 15.9 μm (mean ± SD, n=35). The replating
efficiency showed a dramatic decline between primary and secondary sphere colonies. When
the primary spheres were trypsinized and incubated in serum-free floating culture, secondary
colonies were generated (Fig. 1F) at a level of approximately 15 ± 1 (n=3) per dish of 10,000
cells. This suggests that HCECs have the capacity for self-renewal and formation of sphere
colonies, but this capacity is limited.
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 Figure 1. Sphere formation from donor human corneal endothelium. (A) Anterior view of a human cornea and a dia‐
gram of the corneal epithelium and stroma. Stromal keratocytes were isolated from specimens obtained from both
the peripheral cornea (7.5-10.0 mm in diameter) and the central cornea (7.5 mm in diameter). (B-F) Sphere formation
by human corneal endothelial cells (HCECs). After disaggregation into single cells, HCECs were plated at a density of
10 viable cells/μL in basal medium (B). More than 99% of the cells were single cells on day 0. (C) Spheres were com‐
pletely DiI-positive or DiI-negative after culture at a density of 10 viable cells/μL. (D) The mean (±SD) sphere diameter
was 88.3 ± 15.9 μm on day 10. (E) Each sphere colony was labeled with BrdU on day 10. (F) Secondary spheres gener‐
ated after the dissociation of primary spheres. The replating efficiency was much lower than that of the primary
spheres. Scale bar=100 μm. (G) The number of primary spheres obtained was compared between the peripheral and
central regions of the cornea. The number of sphere colonies obtained from the peripheral cornea (n=14) after 10
days of culture was significantly higher than that obtained from the central cornea (n=10) (unpaired t-test). This ex‐
periment was repeated 3 times using different donor corneas, and representative data are shown as the mean ± SD.
*P<0.0001. These figures were modified from Yokoo et al. (2005) and Yamagami (2007) with permission.
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3.2. Distribution of sphere colonies derived from human Corneal Endothelial cells
HCECs were obtained from the central  cornea (up to  7.5  mm from the center)  and the
peripheral cornea (from 7.5 to 10 mm) (Fig. 1A). As a result, the number of primary sphere
colonies per 5,000 cells (mean ± SD) was significantly higher when peripheral HCECs were
used (13.6 ± 3.5 spheres/5,000 cells) than when central HCECs were used (3.3 ± 1.6 spheres/
5,000 cells) (Fig. 1G). The rate of sphere formation by HCECs from the peripheral cornea
was  approximately  4  times  that  for  HCECs from the  central  cornea  in  repeated experi‐
ments (data not shown).
It has generally been accepted that human CE does not proliferate after birth, but our findings
and some previous reports suggest that the CE may undergo slow proliferation in vivo. In 2003,
Amann et al. demonstrated that paracentral and peripheral HCECs exist at a higher density
than central HCECs by specular microscopy and histological observation of donor corneas.
The presence of slowly proliferating HCEC precursors in the peripheral cornea could explain
this higher cell density at the periphery. Otherwise, the cell density should be uniform
throughout the corneal endothelium, because it tends to equalize over time. Another sugges‐
tive point is the outcome of Sato’s method of anterior–posterior refractive surgery that involves
making multiple peripheral and midperipheral incisions in the endothelium and stromal layer
from the anterior chamber to treat myopia (Kanai et al., 1982; Kawano et al., 2003). This type
of radial keratotomy performed via the anterior chamber leads to a decrease of HCECs many
years later, possibly as a result of the corneal incisions causing more rapid cell loss than would
occur with normal aging (Kanai et al., 1982; Kawano et al., 2003). It is possible that direct
damage to HCEC precursors slows their proliferation, so that replacement of CECs decreases.
The third point to consider is the outcome of corneal transplantation for various conditions
associated with damage to the cornea, such as bullous keratopathy, keratoconus, and corneal
leukoma. In hosts who retain their peripheral CE, such as patients with keratoconus, the grafts
survive for much longer than in hosts with loss of the peripheral endothelium, such as patients
with bullous keratopathy (Boisjoly et al., 1993; Williams et al., 1992; Yamagami et al., 1996).
Keratoconus patients are typically younger than those with bullous keratopathy, so it could
be suggested that their peripheral endothelium has greater proliferative potential because of
this age difference, but differentiation of CEC precursors from the host cornea augmenting
viable cells from the graft may be another reason for the longer survival of grafts after
transplantation for keratoconus compared with bullous keratopathy. Therefore, when full-
thickness corneal transplantation is done, a larger graft may be preferred for eyes with bullous
keratopathy because it can supply more HCEC precursors, whereas a smaller graft may allow
the optimum use of host-derived HCEC precursors in patients with keratoconus.
3.3. Characterization of primary spheres derived from human Corneal Endothelium
Immunocytochemical analysis of 10-day spheres was performed as follows. The spheres were
fixed with methanol (Wako Pure Chemical Industries) in phosphate-buffered saline (PBS) for
10 minutes, washed in PBS, and incubated for 30 minutes with 3% bovine serum albumin (BSA)
in PBS containing 0.3% Triton X20 (BSA/PBST) to block nonspecific staining. Then, the spheres
were incubated for 2 hours at RT with the following specific primary antibodies diluted in
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BSA/PBST: mouse anti-vimentin monoclonal antibody (mAb) (1:300; Dako, Glostrup, Den‐
mark), mouse anti-nestin mAb (1:200; BD PharMingen, San Diego, CA), rabbit anti-p75
neurotrophin receptor (p75 NTR) polyclonal antibody (pAb) (1:200; Promega Corp., Tokyo,
Japan), mouse anti-neurofilament 145 mAb (NFM, 1:400; Chemicon, Temecula, CA), rabbit
anti 3-tublin pAb (1:2000; Covance Research Products, Denver, PA), rabbit anti-glial fibrillary
acidic protein (GFAP) pAb (1:400; Dako), mouse anti-O4 mAb (1:10; Chemicon), rabbit anti-
peripherin pAb (1:100; Chemicon), and mouse anti-α-smooth muscle actin (α-SMA) mAb
(1:200; Sigma-Aldrich). As a control, mouse IgG (1:1000; Sigma-Aldrich) or normal rabbit
serum (1:1000; Dako) was used instead of the primary antibody. After the spheres were washed
in PBS, incubation was done for 1 hour at RT with the appropriate secondary antibody diluted
in BSA/PBST. The secondary antibodies were fluorescent-labeled goat anti-mouse IgG (Alexa
Fluor 488, 1:200; Molecular Probes) and fluorescent-labeled goat anti-rabbit IgG (Alexa Fluor
594, 1:400; Molecular Probes). Nuclei were counterstained with Hoechst 33342 (1:2000;
Molecular Probes). After another wash in PBS, the spheres were examined under a laser
scanning confocal microscope (Fluoview; Olympus, Tokyo, Japan). When anti-O4 or anti-
p75NTR mAb was used, the permeabilization step was omitted.
Figure 2A shows a bright-field image of a typical sphere colony. Spheres derived from HCECs
were not stained by nonimmune mouse IgG (Fig. 2D) or normal rabbit serum (Fig. 2G). Nestin
has been used as a marker for the detection of immature neural progenitor cells in multipo‐
tential sphere colonies derived from the brain (Gage, 2000), skin (Toma et al., 2001), inner ear
(Li et al., 2003), retina (Tropepe et al., 2000), corneal epithelium (Mimura et al., 2010a; Yokoo
et al., 2008), corneal stroma (Amano et al., 2006; Mimura 2008a, 2008b; Uchida et al., 2005;
Yamagami et al., 2007), and CE (Amano et al., 2006; Mimura 2005a, 2005b, 2005c, 2007, 2010b;
Yokoo et al., 2005, Yamagami, 2006, 2007). Expression of α-SMA (a marker of mesenchymal
myofibroblasts) and expression of p75 NTR (a marker of neural crest stem cells) was also
investigated by immunocytochemistry because HCECs are derived from the neural crest. Cells
in the spheres showed immunoreactivity for nestin (Fig. 2B) and for α-SMA (Fig. 2C), but not
for p75 NTR (data not shown). Next, the spheres were immunostained for various neural
markers. As a result, spheres were found to be positive for an immature neuronal marker (β3-
tubulin, Fig. 2E) and an astroglial marker (GFAP, Fig. 2F), but not a mature neuronal marker
(NFM), an oligodendroglial marker (O4), or a peripheral nerve neuronal marker (peripherin;
data not shown). These findings indicated that spheres isolated from human donor CE contain
bipotential precursors that are capable of undergoing differentiation into mesenchymal cells
and neuronal cells.
3.4. Secondary sphere formation
To further evaluate the proliferative capacity of HCECs, cells from the primary spheres were
passaged under the same conditions as those used for the initial sphere culture. On day 10,
primary spheres were treated with 0.05% trypsin/0.02% EDTA and dissociated into single cells,
which were added to 24-well culture plates at a density of 10 cells/μL in medium containing
primary culture supernatant. These cells were then incubated for a further 10 days in basal
medium.
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Secondary spheres were generated from the dissociated primary spheres, but the yield of
secondary sphere colonies was lower than after primary culture. Although self-renewal
potential was indicated by the ability of cells from individual primary spheres to form
secondary spheres, this potential was limited, as evidenced by the failure of sphere formation
at the third passage. These results indicated that the precursor cells had a limited proliferative
capacity. Photographs of representative secondary spheres are shown in Figure 1F.
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Figure 2. Immunocytochemistry (A-H) and RT-PCR analysis (I) of sphere colonies and their progeny. (A) Bright-field im‐
age of a typical sphere colony. (B) Immunostaining of the entire sphere on day 10 identifies cells expressing nestin, a
marker of immature cells. (C-G) Spheres show immunostaining for a mesenchymal myofibroblast marker (α-SMA, C),
an immature neuronal marker (β3-tubulin, E), and an astroglial cell marker (GFAP, F), indicating that both mesenchy‐
mal and neuronal differentiation have occurred. Sphere colonies derived from HCECs are not stained by nonimmu‐
nized mouse IgG (D) or normal rabbit serum (G). Differentiated cells derived from primary spheres are double
immunostained by nestin and β3-tubulin, indicating that the colonies contain immature (undifferentiated) cells. (I) RT-
PCR analysis of cells from spheres and their progeny. GAPDH gene expression is detected in the sphere colonies and
their progeny (30 cycles), but not when reverse transcription is omitted. Nestin, α-SMA, β3-tubulin, and GFAP genes
are detected in both spheres and their progeny, but not when total RNA is processed without reverse transcription (35
cycles). Scale bars=100μ m (A-G) or 200μ m (H). Figures are modified from Yokoo et al. (2005) with permission.
3.5. Differentiation of sphere colonies
Individual primary spheres (day 10) were transferred to 13 mm glass coverslips coated with
50 μg/ml poly-L-lysine (PLL) and 10 μg/ml fibronectin (BD Biosciences, Billerica, MA) in
separate wells, as described previously (Reynolds & Weiss, 1992). To promote differentiation,
1% fatal bovine serum (FBS) was added to the basal medium, and culture was continued for
another 7 days. Immunocytochemical examination of spheres and their progeny was per‐
formed after 7 days of adherent culture on glass coverslips.
To investigate whether sphere progeny possessed the characteristics of mesenchymal or neural
cells, single spheres (day 10) were transferred onto PLL/laminin-coated glass coverslips in
medium containing 1% or 15% FBS or onto bovine ECM-coated culture plates in medium
containing 15% FBS. Spheres remained adherent to the PLL/laminin-coated glass coverslips,
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but cells migrated out from the spheres grown on glass coverslips coated with bovine ECM
alone. After 7 days, some of the cells that had migrated from the spheres showed double
immunostaining for nestin and β3-tublin (Fig. 2H), as has been reported for human scalp tag–
derived cells (Toma et al., 2001). However, there was no staining of cells migrating out of the
spheres for α-SMA, p75NTR, NFM, peripherin, GFAP, or O4.
RT-PCR was performed to examine the expression of genes governing the proteins detected
by immunocytochemistry in the spheres and their progeny (Fig. 2I). GAPDH mRNA was
detected in both spheres and progeny, but not in the control assay without the RT reaction.
Expression of nestin,β 3-tublin, GFAP, and α-SMA mRNA was detected in the spheres and
adherent progeny after 35 PCR cycles. However, mRNAs for NFM, p75NTR, and peripherin
were not found under any cycling conditions. Nestin andβ 3-tublin mRNAs were also detected
in HCECs from primary culture.
These findings indicated that spheres isolated from human CE contain bipotential precur‐
sors,  yielding  progeny  that  display  the  morphologic  characteristics  of  HCECs.  Taken
together,  these results suggest that precursors from the CE remain close to the tissue of
origin and undergo differentiation into CECs. Because precursors should ideally differenti‐
ate efficiently to produce their tissue of origin, precursors obtained from the CE may be
more appropriate for tissue regeneration or cell  transplantation than those derived from
the multipotential stem cells.
4. Isolation of precursors from cultured human Corneal Endothelial cells
4.1. Culture of human Corneal Endothelial cells
As mentioned in sections 3.1-3.4, we have isolated precursor cells from human donor corneas
(Yamagami et al. 2007; Yokoo et al., 2005). However, the number of precursors that can be
isolated from a cornea is insufficient for corneal endothelial regeneration, so establishment of
a mass production method for precursor cells is needed before clinical application can be
attempted. Accordingly, we isolated spheres from cultured HCECs and investigated whether
the cells of these spheres had CE-like functions. We also tested the effect of injecting these
spheres into the anterior chamber (instead of full-thickness corneal transplantation) in a rabbit
model of bullous keratopathy, representing a state in which corneal endothelial defects exist.
Several groups have established HCEC culture techniques (Chen et al.,  2001; Engelmann
&  Friedl  1989;  Miyata  et  al.,  2001;  Yue  et  al.  1989).  Various  growth  factors  have  been
reported to influence the proliferation of cells cultured from human CE, including fibroblast
growth factor (Chen et al., 2001; Engelmann 1988, 1989, 1995; Yue et al. 1989; Samples et
al.,  1991), epidermal growth factor (Chen et al.,  2001; Samples et al.,  1991; Schultz et al.,
1992; Yue et al. 1989), nerve growth factor (Chen et al., 2001), and endothelial cell growth
supplement (Blake et al.,  1997; Yue et al.  1989).  In addition, cell  attachment and growth
can be supported by seeding cells onto an artificial matrix, such as chondroitin sulfate or
laminin (Engelmann et al.,  1988),  laminin-5 (Yamaguchi et al.,  2011),  extracellular matrix
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secreted  by  bovine  corneal  endothelial  cells  (Blake  et  al.,  1997;  Miyata  et  al.,  2001),  or
fibronectin/type I collagen coating mix (Joyce & Zhu, 2004).
In our studies, HCECs were isolated and cultured according to the published protocols of
Joyce and our laboratory with some modifications (Chen et al.,  2001; Joyce & Zhu, 2004;
Miyata et al., 2001). Briefly, Descemet’s membrane was carefully dissected with the intact
CE. After centrifugation, membrane strips were incubated in 0.02% EDTA solution at 37ºC
for 1 hour to loosen intercellular junctions. Then isolated cells were plated in 6-well tissue
culture plates that had been precoated with undiluted fibronectin/type I collagen coating
mix, and incubation was done at 37ºC under a humidified atmosphere with 5% CO2. After
primary cultures reached confluence, cells were subcultured at a 1:4 ratio, and cells from
the 4th to 6th passages were used.
4.2. Isolation and characterization of sphere colonies
Cells from the 4th or 5th passages were used in this study. HCECs were incubated in 0.2%
EDTA at 37ºC for 5 minutes and then were dissociated into single cells by pipetting with
a flame-polished Pasteur pipette. The viability of the isolated HCECs was >90% as shown
by trypan  blue  staining.  The  sphere-forming  assay  was  used  for  primary  culture  (Rey‐
nolds & Weiss, 1992). Cells were plated at a density of 10 viable cells/μL (40,000 cells per
well  or  1,420 cells/cm2)  in the uncoated wells  of  60-mm culture dishes.  The basal  medi‐
um  was  Dulbecco’s  modified  Eagle’s  medium  (DMEM)/F12  supplemented  with  B27,
epidermal growth factor (EGF, 20 ng/mL), and basic fibroblast growth factor (bFGF, 20 ng/
mL).  A  methylcellulose  gel  matrix  (1.5%;  Wako)  was  added to  the  medium to  prevent
reaggregation of the cells (Gritti et al., 1999; Kawase et al., 2004). To distinguish growing
spheres from dying cell clusters, only spheres with a diameter of more than 50 μm were
counted. For passaging, primary spheres were harvested on day 7 and treated with 0.5%
EDTA for dissociation into single cells,  which were plated in 24-well  culture plates at  a
density of  10 cells/μL.  Then culture was continued for another 7 days in basal  medium
containing the methylcellulose gel matrix.
Spheres formed after 7 days of culture (Fig. 3A), while nonproliferating cells were eliminated.
Many of the cells in each sphere were BrdU-positive (Fig. 3B), indicating that such cells were
proliferating. These findings suggested that the spheres had developed from single HCECs
and that the sphere-forming cells displayed proliferative activity. The number of sphere
colonies obtained after 7 days of culture was 44 ± 10 per 10,000 cells (mean ± SD). Replating of
primary spheres to generate secondary sphere colonies was less efficient, indicating that the
cells only had limited self-renewal capacity.
On immunostaining, the spheres were positive for nestin (Fig. 3C), which is a marker of
immature cells (Lendahl et al., 1990), and for α-SMA (Fig. 3D), a mesenchymal myofibro‐
blast  marker.  We  previously  demonstrated  that  primary  spheres  derived  from  human
donor CE express β-III tubulin and GFAP, a mature glial cell marker, as well as nestin and
α-SMA (Fig.  2),  but  β-III  tubulin and GFAP were negative in the spheres derived from
cultured HCECs.
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Figure 3. Immunocytochemistry (A-F) and RT-PCR analysis (G) of sphere colonies derived from cultured HCECs were
their progeny. Cultured HCECs were disaggregated into single cells and plated at a density of 10 viable cells/μL in bas‐
al medium containing a methylcellulose gel matrix to prevent reaggregation. (A) A representative day 7 sphere. (B)
Cells in a sphere colony labeled by BrdU on day 7. A total of 44± 10 primary spheres were generated per 10,000 cells
(mean ± SD). Scale bar=50 μm. (C-F) A day 7 sphere shows staining for nestin (C) and α-SMA (D). Less than 5% of the
sphere progeny cells were stained by the mesenchymal cell marker α-SMA (E, arrow). There is no staining by control
IgG (F). Scale bar=100 µm. (G) RT-PCR of spheres and progeny. cDNA was obtained from spheres and from their prog‐
eny cultured in 1% FBS or 15% FBS. GAPDH was detected in all samples, except those reacted without reverse tran‐
scriptase. Nestin mRNA expression was detected in cultured spheres, but not in their progeny cultured in either 1% or
15% FBS. Both the spheres and progeny were positive forα -SMA mRNA. Figures are modified from Mimura et al.
(2005b) with permission.
4.3. Differentiation of sphere colonies
Individual primary spheres (day 7) were transferred to 13-mm glass coverslips coated with 50
μg/mL PLL and 10 μg/mL fibronectin in separate wells (Mimura et al., 2005a). To promote
differentiation, 1% or 15% FBS was added to the basal medium, after which culture was
continued for another 7 days.
Then the spheres were transferred to PLL/fibronectin-coated glass coverslips in 24-well plates
and were cultured in a differentiation medium containing 1% or 15% fetal bovine serum (FBS).
After 7 days, many cells were found to have migrated out of the spheres. Fewer than 5% of
these cells were α-SMA-positive (Fig. 3E), whether cultured with 1% or 15% FBS. All of these
cells were negative for control IgG (Fig. 3F) and for the differentiated epithelial cell marker
cytokeratin 3, as well as for nestin, β-III tubulin, and GFAP (not shown). These findings
indicated that a single sphere colony could give rise to a small population of mesenchymal
cells under clonogenic conditions. Expression of nestin and α-SMA by the spheres, as well as
α-SMA expression by their progeny, was confirmed using RT-PCR (Fig. 3G). Positivity for β-
III tubulin mRNA was only detected in cultures with 1% FBS.
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Spheres derived from donor CE expressed an immature cell marker (nestin), an immature
neuronal marker (β-III tubulin), and a mature glial cell marker (GFAP), while their progeny
expressedβ -III tubulin and nestin, but not GFAP. In contrast, the spheres and progeny
obtained from cultured HCECs did not express neuronal markers and showed decreased
expression of immature cell markers. These findings suggested that the precursors were close
in nature to the original tissue and underwent differentiation during culture. Thus, precursors
obtained from cultured HCECs may be a more appropriate cell source than cells from donor
CE, because precursors that efficiently differentiate into the tissue of origin are ideal for tissue
regeneration or cell transplantation.
4.4. Assessing the pump function of cells derived from spheres
The pump function of four collagen sheets seeded with cells derived from HCEC spheres
was  measured  in  an  Ussing  chamber,  as  reported  previously  with  some  modifications
(Wigham, 1981, 2000; Hodson & Wigham 1983). The collagen sheets were obtained from
the  Nippi  Biomatrix  Research  Institute  (Tokyo,  Japan).  Cells  from  HCEC  spheres  were
suspended at 5.0 × 106 cells in 1.5 mL of culture medium and transferred to circular collagen
sheets (10 mm in diameter). Each sheet was placed in one well of a 24-well plate, and the
plate was centrifuged at 1,000 rpm (176 g) for 10 minutes to enhance cell attachment. Then
the sheets were incubated in culture medium for 2 days, after which nonadherent cells and
debris  were  removed  (Fig.  4A).  Human  donor  corneas  with  the  epithelium  removed
mechanically (n=4), plain collagen sheets (n=4), or HCEC-coated collagen sheets (n=4) were
mounted in the Ussing chamber.
Changes of the potential difference (Fig. 4B) and short circuit current (Fig. 4C) were compared
between human donor corneas without epithelium and HCEC-coated collagen sheets con‐
structed with cells from spheres. The average potential difference and short circuit current of
the HCEC-coated sheets ranged from 81% to 100% at 1, 5, and 10 minutes, corresponding to
the results for normal human donor corneas denuded of epithelium. These findings suggested
that the cultured HCEC spheres could generate CE-like cells with adequate transport activity.
4.5. Migration and proliferation of spheres on rabbit descemet’s membrane
Animals were handled in accordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Primary HCEC spheres (cultured for 7 days) were labeled
with a fluorescent cell tracker (CM-DiI). After the endothelium was gently scraped off four
freshly excised rabbit corneas with a sterile cotton swab, HCEC spheres were applied to the
posterior surface of each cornea. Then the corneas were placed in 24-well plates and main‐
tained in culture medium for 7 days. HCECs that migrated onto the corneas were detected
under a fluorescence microscope, and the area occupied by fluorescent cells migrating from
the spheres was measured with the NIH image program (n=10).
Figure 5A shows cells migrating from DiI-labeled spheres on days 1-7. The mean area covered
by migrating cells per sphere reached 1.2 ± 0.2 mm2 on day 7 (Fig. 5B).
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Figure 5. Migration of sphere-derived cells during culture for 7 days, modified from Mimura et al. (2005b) with per‐
mission. DiI-labeled spheres were seeded onto the denuded Descemet’s membranes of rabbit corneas and cultured
for 1 week in a humidified incubator. (A) Representative photographs of cell migration around an adherent DiI-la‐
beled sphere. Scale bar=100 μm. (B) Mean area occupied by cells migrating from the spheres on each day (n=10).
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Figure 4. Morphology (A) and transport activity (B, C) of cells from cultured HCEC spheres, modified from Mimura et
al. (2005b) with permission. (A) Confluent cells cultured in DMEM containing 10% FBS show the characteristic hexago‐
nal shape of corneal endothelial cells. Changes of the potential difference (B) and short circuit current (C) for human
donor corneas without epithelium and HCEC-coated collagen sheets (mean ± SD). The mean potential difference and
short circuit current after 1, 5, and 10 minutes ranged from 81% to 100% for the HCEC-coated sheets, similar to the
results for human corneas denuded of epithelium, indicating that the HCEC-like cells generated in culture had ade‐
quate transport activity. When Na+ - K+ ATPase inhibitor ouabain was added to the chamber, the potential difference
decreased to 0 mV and the short circuit current declined to 0 μA in all cases.
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5. Treatment of bullous keratopathy with precursors derived from cultured
spheres
5.1. Cryoinjury and injection of spheres into the anterior chamber
Animals were handled in accordance with the ARVO Statement on the Use of Animals in
Ophthalmic and Vision Research. New Zealand White rabbits (weighing 2.0–2.4 kg, n=24) were
anesthetized with an intramuscular injection of ketamine hydrochloride (60 mg/kg; Sankyo,
Tokyo, Japan) and xylazine (10 mg/kg; Bayer, Leverkusen, Germany). To detach the CE from
Descemet’s membrane, a brass dowel cooled in liquid nitrogen was touched onto the cornea
nine times (at the center and at eight peripheral sites). This procedure was repeated twice.
Then the anterior chamber was washed three times with PBS through a 1.5-mm paracentesis.
To estimate the number of spheres needed to cover the inner surface of the cornea (Descemet’s
membrane), DiI-labeled spheres were seeded onto the denuded Descemet’s membrane of
freshly excised rabbit corneas and the mean area covered per sphere was found to be 1.2 ± 0.2
mm2 on day 7 (Fig. 5B). Therefore, it was calculated that 75 spheres were needed to cover a
cornea. To allow for loss of spheres that failed to adhere, 150 DiI-labeled HCEC spheres or 1.0
× 107 HCECs were injected into the anterior chamber of the right eye after cryoinjury. Then the
rabbits were maintained in the eyes-down position (Descemet’s membrane down) for 24 hours
to allow attachment (sphere eyes-down group, n=6). Cryoinjury alone (cryo group, n=6),
injection of cultured HCECs with the eyes-down position being maintained for 24 hours
(HCEC group, n=6), and injection of spheres in the eyes-up position (sphere eyes-up group,
n=6) were also tested as controls. However, injection of cultured HCECs or injecting spheres
in the eyes-up position did not reduce corneal edema in our preliminary study (Mimura T,
unpublished observation, 2003), so these controls were not used in the present study. Each eye
was inspected 2 or 3 times a week and was photographed on postoperative days 7, 14, 21, and
28. Central corneal thickness was measured with an ultrasonic pachymeter having a range of
0 to 1,200 μm (Tomey, Nagoya, Japan) and intraocular pressure was determined with a
pneumatic tonometer (model 30 Classic; Mentor O & O, Norwell, MA) at 1, 3, 7, 14, 21, and 28
days after surgery. The average of three readings was obtained each time. One-way analysis
of variance and Scheffe’s multiple comparison test were used to compare mean values.
5.2. Findings after surgery
Our previous studies had suggested that cultured HCEC precursors have a limited self-
renewal capacity and mainly differentiate into HCEC-like cells. Then we investigated the use
of precursors derived from cultured HCECs in a rabbit model of corneal endothelial damage.
In the cryo and HCEC groups, the mean corneal thickness ranged from 953 ± 182 to 1,200 ± 0
μm (mean ± SD), as shown in Figure 6A. The mean (±SD) corneal thickness of the sphere eyes-
up group (704 ± 174 μm) was significantly less than that of the cryo group (1,011 ± 190 μm;
P=0.006) and the HCEC group (953 ± 182 μm; P=0.022) after 28 days of observation, but the
corneas were still edematous in the eyes-up group (Fig. 6A). In contrast, the corneal thickness
decreased rapidly in the sphere eyes-down group, and the corneas were significantly thinner
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than in the other three groups after 14 (672 ± 90 μm), 21 (483 ± 84 μm), and 28 (394 ± 26 μm)
days (P=0.006; Fig. 6A). Representative anterior segment photographs from the cryo group
(Fig. 6B), HCEC group (Fig. 6C), and sphere eyes-up group (Fig. 6D ) show that the corneas of
rabbits from these groups were edematous and displayed stromal opacity. In contrast, corneas
from the sphere eyes-down group corneas became clear and the anterior chamber was easily
visualized (Fig. 6E). No apparent inflammatory reactions suggesting rejection were observed
by slit lamp microscopy throughout the postoperative period. On day 14, the intraocular
pressure of the sphere eyes-up group was significantly higher than that of the cryo group
(P=0.013). However, there was no increase of intraocular pressure (a possible side effect) on
any other day in any group (Table 1).
Injection of spheres in the eyes-down position, but not injection of differentiated cultured
HCECs or injection of spheres in the eyes-up position, restored endothelial function and
decreased corneal edema in this rabbit model of bullous keratopathy model. These findings
suggest that injection of spheres derived from cultured HCECs and maintenance of an eyes-
down position for 24 hours may be a potential treatment strategy for corneal endothelial
defects that is less invasive compared with conventional full-thickness corneal transplantation.
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Figure 6. Changes of corneal thickness and other findings in a rabbit model of bullous keratopathy, modified from
Mimura et al. (2005b) with permission. (A) Mean corneal thickness decreases gradually in the sphere eyes-down group
(closed circles, n=6). It is significantly less than in the cryo group (open circles, n=6), HCEC group (closed triangles, n=6),
and sphere eyes-up group (open triangles, n=6) on days 14, 21, and 28 (*P<0.001 by one-way analysis of variance and
Scheffe’s multiple comparison test). (B–E) Representative photographs of corneas from each group. The cornea is opa‐
que in the cryo group (B), HCEC group (C), and sphere eyes-up group (D), and the anterior chamber is not well visual‐
ized. In contrast, there is no corneal opacity in the sphere eyes-down group (E).
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Days after Surgery
Group 0 7 14 21 28
Cryo 12.7 ± 1.9 10.8 ± 1.8 10.5 ± 4.3* 11.0 ± 1.6 10.2 ± 1.5
HCEC 11.8 ± 1.5 11.6 ± 2.8 12.3 ± 4.5 11.8 ± 2.2 11.5 ± 2.8
Sphere (eyes-up) 13.2 ± 2.0 9.9 ± 1.9 17.2 ± 4.0* 13.3 ± 3.4 10.5 ± 3.1
Sphere (eyes-down) 13.5 ± 3.2 8.7 ± 2.1 14.8 ± 2.2 13.7 ± 1.7 11.7 ± 1.9
Table 1. Intraocular pressure in each group after surgery (mm Hg). Data represent the mean ± SD for six rabbits.
*P=0.013 by one-way analysis of variance and Scheffe’s multiple comparison test.
5.3. Histologic findings
Examination of hematoxylin & eosin-stained sections revealed that corneas from the cryo
group (Fig. 7A), HCEC group (Fig. 7B), and sphere eyes-up group (Fig. 7C) were thickened
and no cells could be detected on Descemet’s membrane. In contrast, a monolayer of cells had
formed on Descemet’s membrane in the sphere eyes-down group, and there was no edema
and no mononuclear cell infiltration of the posterior stroma (Fig. 7D). In the cryo group (Figs.
8A, 8E), HCEC group (Figs. 8B, 8F), and sphere eyes-up group (Figs. 8C, 8G), no HCECs (Figs.
8A–C) with positive staining for DiI (Figs. 8E–G) were found on Descemet’s membrane at the
central cornea in flat mount preparations. In contrast, HCEC-like hexagonal cells were detected
at this site in the sphere eyes-down group (Fig. 8D). These cells were DiI-positive (Fig. 8H),
indicating that they had originated from the injected spheres and not from the host. In the
sphere eyes-down group, DiI-negative cells were present in the peripheral cornea, but all cells
in the central and paracentral (8 mm in diameter) cornea were DiI-positive. The density of
HCECs in the six grafts of the sphere eyes-down group at 28 days after surgery ranged from
2,625 to 2,875 cells/mm2, with a mean (±SD) value of 2,781 ± 92 cells/mm2. Before surgery, the
density of endothelial cells in the rabbit cornea was from 3,300 to 3,500 cells/mm2. In the sphere
eyes-down group, very few DiI-positive cells were detected in the inferior trabecular mesh‐
work or on the iris, whereas a number of DiI-positive cells were attached at these sites in the
HCEC group and the sphere eyes-up groups (data not shown).
Cells adherent to the inner surface of the cornea (Descemet’s membrane) were DiI-positive in
the sphere eyes-down group, indicating that these were HCECs derived from the injected
spheres and not residual host cells. In addition, DiI-positive cells were rarely detected in the
trabecular meshwork or on the surface of the iris, so the spheres mainly attached to and spread
over the cornea in the eyes-down group. These results suggested that sphere-derived HCECs
could restore corneal hydration after sphere transplantation.
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Figure 7. Histologic findings, modified from Mimura et al. (2005b) with permission. In the cryo group (A), HCEC group
(B), and sphere eyes-up group (C), stromal edema is prominent and no cells are present on Descemet’s membrane at
the central cornea. In contrast, a monolayer of cells can be detected on Descemet’s membrane in the sphere eyes-
down group (D). There is no mononuclear cell infiltration near Descemet’s membrane, suggesting no rejection of the
xenogeneic cells (D). Scale bar=100 μm, hematoxylin & eosin stain.
Figure 8. Flat mount preparations with phase-contrast (A–D) and fluorescence (E–H) microscopy, modified from Mim‐
ura et al. (2005b) with permission. At the central cornea, there are no cells on Descemet’s membrane in the cryo group
(A, E), HCEC group (B, F), and sphere eyes-up group (C, G). In contrast, HCEC-like hexagonal cells are present in the
sphere eyes-down group (D). These cells are also DiI-positive (H). Scale bar=100 μm.
5.4. Advantages of transplanting CE precursors
For regenerative medicine,  amplification of  stem cells  is  required to treat  each tissue or
organ. Although much attention has been paid to maintaining the undifferentiated nature
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("stemness") of stem cells and promoting their amplification, the molecular mechanisms of
stem cell replication and differentiation are still not fully understood. In comparison with
amplification of adult stem cells, cultured cells can be used more easily to produce tissue-
committed precursors by the sphere-forming assay, as demonstrated in our studies. Similar
techniques  to  produce  abundant  precursors  should  be  tested  for  various  tissues  as  a
method of obtaining cells for regenerative medicine.
Transplantation of HCEC precursors into the anterior chamber has several advantages over
penetrating  keratoplasty  with  a  full-thickness  donor  cornea.  For  example,  complications
associated  with  open-sky  surgery  (expulsive  hemorrhage  and the  risk  of  wound dehis‐
cence) are essentially eliminated. In addition, several postoperative complications, such as
irregular  astigmatism,  wound leakage,  corneal  infection,  neovascularization,  and  persis‐
tent epithelial defects, can be avoided when using the combined approach. After conven‐
tional  full-thickness  human  corneal  allografting  with  local  and/or  systemic
immunosuppressants, the leading cause of failure is graft rejection (Price et al., 1991; Wilson
& Kaufman, 1990). Although there was no apparent inflammatory reaction histologically,
we cannot deny the possibility of allograft rejection over the long term because nonadher‐
ent  cells  should  migrate  out  of  the  anterior  chamber.  It  is  noteworthy  that  injection  of
HCEC precursors did not improve bullous keratopathy created by scraping off endothe‐
lial  cells  in rabbits (data not shown).  This may be because cryoinjury to the cornea, but
not endothelial cell scraping, promoted the proliferation and migration of HCEC s that led
to recovery of corneal clarity.
6. Conclusion
We demonstrated that the endothelium from the peripheral region of the human cornea
contains a higher density of precursors with strong proliferative capacity compared to the
central endothelium. These HCEC precursors are able to differentiate into both mesenchy‐
mal and neural  cells.  We have also established a method for  mass production by isola‐
tion of precursors from cultured HCECs using the sphere-forming assay. Transplantation
of spheres into the anterior chamber and short-term maintenance of the eyes-down position
was shown to  be  a  simple  and effective  treatment  strategy in  our  rabbit  model  of  bul‐
lous  keratopathy.  This  method  of  managing  corneal  endothelial  defects  may  have  the
potential  to  replace  conventional  full-thickness  corneal  grafting  and compensate  for  the
worldwide shortage of donor corneas.
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